Please login to the form below

Not currently logged in
Email:
Password:

Rebecca Grant to lead newly-formed Burson Cohn & Wolfe UK

Experienced leader takes on merged comms group

Rebecca Grant

Cohn & Wolfe UK managing director Rebecca Grant (pictured) is to head up the newly-merged Burson Cohn & Wolfe UK.

The move brings together two well-established agencies, Burson Marsteller and Cohn and Wolfe - both owned by marketing communication services giant WPP.

The merger creates a company which become the world’s third largest PR firm, and has come about against a background of double digit growth over the past five years, while Burson Marsteller fared less well.

The mergers has seen the departure of Burson-Marsteller’s UK CEO Stephen Day and its worldwide president Kevin Ball.

Now Rebecca Grant is taking the helm of the new firm's UK division. Her career history has included senior roles at agencies including Red Consultancy and Weber Shandwick, where she was senior director and co-head consumer, Europe.

She initially joined Cohn & Wolfe back in 2011 as managing director consumer marketing, then subsequently served as its UK managing director and head of consumer marketing EMEA.

It was in this role that she reported to Scott Wilson, who was named Burson Cohn & Wolfe’s president for the Europe and Africa regions earlier this year.

Cohn & Wolfe was among the winners at the recent Communiqué Awards, earning the Innovation in Healthcare Award for its work on the Think Act Breathe Asthma Chatbot for Boehringer Ingelheim.

Article by
Gemma Jones

10th July 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....